How often are the AMR parliamentary roundtablespage held?

Twice a year, in Westminster. Each session runs for two hours and is scheduled to parliamentary sitting patterns so that parliamentarians can attend.

Who attends an AMR parliamentary roundtable?

Around twenty senior stakeholders: parliamentarians, researchers, the UK Health Security Agency, professional bodies such as the British Society for Antimicrobial Chemotherapy, and patient advocates.

How can I propose a topic for the next roundtable?

Researchers, professional bodies and patient organisations can submit a proposal through the Engage page. The agenda for the next roundtable is open.

The standing calendar

AMR Parliamentary Roundtables

Two hours in Westminster, on a shared agenda. The roundtable was scheduled to parliamentary sitting patterns, so that MP champions can actually be in the room — and each one closes with actionable recommendations with measurable indicators.

House of CommonsRoundtable with Member of Parliament

120Minutes, start to finish

20+Multi-stakeholders in the room

4Outputs

Two hours, four movements

15 min

Welcome & context

The host MP opens; the chair sets the question the session has to answer.

45 min

Evidence

Short, non-technical presentations from researchers, the regulator, the professional body and a AMR patient advocate

45 min

Discussion & co-creation

Facilitated discussion in which parliamentarians and experts draft the actionable recommendations

15 min

Summary & next steps

The chair reads the recommendations back, and the policy brief is released after that.

This AMR roundtable, provide five actionable recommendations and evidence support report

The calendar

18 May 2026

House of Commons, Westminster

Translating AMR Research into Parliamentary Action

The AMR roundtable. The agenda deliberately shifted from scrutiny to delivery, building on written evidence submitted to the Public Accounts Committee AMR inquiry. Five recommendations were agreed in the room and four outputs followed.

Hosted by Andrew Lewin MPDr Danny Chambers MPChaired by Prof Sam SalekUKHSA · BSAC · patient voice

CompleteRead the brief →

In the room

Andrew Lewin MPHost
Andrew Lewin MPHost
Professor Sam SalekChair · University of Hertfordshire
Dr Alicia DemirjianHead of the AMR and Prescribing Team, UKHSA
Professor Andrew SeatonPresident, British Society for Antimicrobial Chemotherapy (BSAC)
Vanessa CarterAMR survivor · Founder, The AMR Narrative
Professor Zoe AslanpourAntimicrobial stewardship research, University of Hertfordshire
Dr Rasha Abdelsalam ElshenawyConvenor and Principal Investigator, and Led this AMR Parliamentary Award, AMR/AMS Consultant, Senior Lecturer, University of Hertfordshire

The Five Recommendations

Embed stewardship across practice
Operationalise integrated One Health
Strengthen diagnostics, data, AI
Sustain innovation, regulatory pathways
Establish permanent research–policy interface

Session record

Date18 May 2026
VenueHouse of Commons, Westminster
FormatTwo hours · four movements · recommendations drafted in the room
ConvenorDr Rasha Abdelsalam Elshenawy, Researcher, Principal Investigator, ESRC Award
Evidence-baseWritten evidence to the Public Accounts Committee AMR inquiry
SupportESRC Impact Acceleration Account, University of Hertfordshire

Final Output from this AMR Parliamentary Roundtable

Output 01

Policy brief

Five actionable recommendations

Output 02

Peer-reviewed paper

The translation methodology, documented so that it can be replicated — with participating from member parliaments champions

Output 03

Public record

For knowledge mobilisation, and include public summary report

Output 04

Uptake report

Final report for all AMR parliamentary roundtable activities

Propose a topic

This AMR parliamentary roundtable aimed to connect researchers, professional bodies and patient advocate, academics, researchers, organisations can put forward evidence, with open discussions

Submit your Idea Email the Interface